Its serum levels are increased in most patients compared to age-matched healthy donors5,6 and it is widely accepted that IL-8 prolongs CLL cell survival in an autocrine fashion5,7–9. Here, CXCL8 is linked to B-cell chronic lymphocytic leukemia.